Mobile Health Program for Blood Pressure After Brain Bleeding
Tests a phone-based health program for high blood pressure in brain bleed survivors.
Plain-language title generated from the registry record
Registry title: MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors
Key facts
- Where
- Hong Kong, Hong KongSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT05830305, who can take part
Where in Hong Kong
- Queen Mary HospitalHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Hong Kong
- Trial code
- NCT05830305
- Record updated
- 6 January 2026
- Original description
This randomized controlled trial investigates the efficacy and safety of mobile health intervention in managing hypertension after Intracerebral Hemorrhage (ICH).Read full original descriptionShow less
MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors
This randomized controlled trial investigates the efficacy and safety of mobile health intervention in managing hypertension after Intracerebral Hemorrhage (ICH).
Inclusion: Primary ICH Diagnosis; Age ≥ 18 years; Discharge Modified Rankin Scale of ≤4.
Exclusion: Contraindication for intensive and rapid lowering of blood pressure (Known >70% cerebral vascular stenosis; History of fall, dizziness or syncope due to hypotension; Any other medical condition that is deemed contraindicated for low blood pressure; Severe renal impairment (Estimated glomerular filtration rate using CKD-EPI formula <30 ml/min/1.73m2); Severe liver impairment (Child-Pugh C cirrhosis); Known contraindication or allergy to two or more anti-hypertensive classes; Bleeding tendency (Platelet count < 75 x 10\^9/L; Known coagulation disorder); Expected life expectancy of <1 year; Patient or caregiver does not have access to WeRISE App; Patient or caregiver does not know how to use WeRISE App ; Inability to perform home BP monitoring; Inability to participate in follow-up activity.